LUMEN TECHNOLOGIES INC (1CYTH.MI) Forecast, Price Target & Analyst Ratings

BIT:1CYTH • US5502411037

7.345 EUR
-1.79 (-19.61%)
Last: Jan 16, 2026, 07:00 PM

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for LUMEN TECHNOLOGIES INC (1CYTH.MI).

Forecast Snapshot

Consensus Price Target

Price Target
€6.27
-14.58% Downside

Next Earnings Forecast

Earnings Estimate
Release DateFeb 3, 2026
PeriodQ4 / 2025
EPS Estimate-$0.27
Revenue Estimate3.1B

ChartMill Buy Consensus

Rating
54.44%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
€6.27
Upside
-14.58%
From current price of €7.35 to mean target of €6.27, Based on 18 analyst forecasts
Low
€2.63
Median
€6.70
High
€10.04

Price Target Revisions

1 Month
41.41%
3 Months
35.25%

Price Target Summary

18 analysts have analysed 1CYTH.MI and the average price target is 6.27 EUR. This implies a price decrease of -14.58% is expected in the next year compared to the current price of 7.345.
The average price target has been revised upward by 35.25% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

1CYTH Current Analyst Rating1CYTH Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

1CYTH Historical Analyst Ratings1CYTH Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
54.44%
1CYTH.MI was analyzed by 18 analysts. The buy percentage consensus is at 54. So analysts seem to be rather neutral about 1CYTH.MI.
In the last month the buy percentage fell by 15 points. So the trust of analysts is decreasing.
1CYTH.MI was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release DateFeb 3, 2026
PeriodQ4 / 2025
EPS Estimate-$0.27
Revenue Estimate3.1B
Revenue Q2Q-6.88%
EPS Q2Q-405.20%
Number of Analysts13

Next Earnings Revisions

Revenue (1 Month)
0.23%
Revenue (3 Months)
0.26%
EPS (1 Month)
-33.18%
EPS (3 Months)
-23.85%

Next Earnings Summary

1CYTH.MI is expected to report earnings on 2/3/2026. The consensus EPS estimate for the next earnings is -0.27 EUR and the consensus revenue estimate is 3.10B EUR.
The next earnings revenue estimate has been revised upward by 0.26% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
1CYTH.MI revenue by date.1CYTH.MI revenue by date.
17.478B
-11.22%
14.557B
-16.71%
13.108B
-9.95%
12.659B
-3.43%
11.724B
-7.39%
11.316B
-3.48%
10.959B
-3.15%
10.887B
-0.66%
10.933B
0.42%
10.306B
-5.73%
9.635B
-6.51%
9.62B
-0.16%
EBITDA
YoY % growth
1CYTH.MI ebitda by date.1CYTH.MI ebitda by date.
6.532B
-21.34%
4.215B
-35.47%
3.433B
-18.55%
3.296B
-3.99%
3.436B
4.25%
3.548B
3.26%
3.416B
-3.72%
3.457B
1.20%
3.496B
1.13%
3.545B
1.40%
3.413B
-3.72%
3.421B
0.23%
EBIT
YoY % growth
1CYTH.MI ebit by date.1CYTH.MI ebit by date.
3.293B
-23.15%
1.23B
-62.65%
477M
-61.22%
-363.649M
-176.24%
467.19M
228.47%
661.88M
41.67%
820.08M
23.90%
905.76M
10.45%
1.055B
16.48%
1.202B
13.93%
1.255B
4.41%
N/A
Operating Margin
1CYTH.MI operating margin by date.1CYTH.MI operating margin by date.
18.84%8.45%3.64%-2.87%3.98%5.85%7.48%8.32%9.65%11.66%13.03%N/A
EPS
YoY % growth
1CYTH.MI eps by date.1CYTH.MI eps by date.
1.55
-18.85%
0.19
-87.74%
-0.21
-210.53%
-0.64
-205.66%
-0.47
26.11%
-0.23
52.33%
0.02
109.02%
0.06
200.00%
0.08
33.33%
0.11
37.50%
N/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.27
-405.20%
-0.19
-45.62%
-0.13
-342.68%
0.08
139.27%
-0.11
61.63%
Revenue
Q2Q % growth
3.1B
-6.88%
3.02B
-5.09%
2.918B
-5.63%
2.839B
-8.03%
2.831B
-8.68%
EBITDA
Q2Q % growth
800.48M
-74.26%
854.29M
4.18%
849.73M
-40.41%
805.59M
-58.88%
854.25M
6.72%
EBIT
Q2Q % growth
35.462M
-76.97%
86.376M
-19.27%
66.467M
165.87%
21.093M
118.18%
-114.24M
-422.15%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

1CYTH.MI Yearly Revenue VS Estimates1CYTH.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B
1CYTH.MI Yearly EPS VS Estimates1CYTH.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 1 2

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-2.49%
EPS Next 5 Year
18.04%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-5.11%
Revenue Next 5 Year
-3.84%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
73.55%
EBIT Next 5 Year
38.48%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

LUMEN TECHNOLOGIES INC / 1CYTH.MI Forecast FAQ

What is the average price target for LUMEN TECHNOLOGIES INC (1CYTH.MI) stock?

18 analysts have analysed 1CYTH.MI and the average price target is 6.27 EUR. This implies a price decrease of -14.58% is expected in the next year compared to the current price of 7.345.


What is the next earnings date for 1CYTH stock?

LUMEN TECHNOLOGIES INC (1CYTH.MI) will report earnings on 2026-02-03, after the market close.


Can you provide the consensus estimates for LUMEN TECHNOLOGIES INC next earnings?

The consensus EPS estimate for the next earnings of LUMEN TECHNOLOGIES INC (1CYTH.MI) is -0.27 EUR and the consensus revenue estimate is 3.10B EUR.


What is the consensus rating for 1CYTH stock?

The consensus rating for LUMEN TECHNOLOGIES INC (1CYTH.MI) is 54.4444 / 100 . This indicates that analysts generally have a neutral outlook on the stock.